释义 |
- References
- Further reading
{{Underlinked|date=June 2016}}{{Infobox_gene}}Serine/threonine-protein kinase TAO3 is an enzyme that in humans is encoded by the TAOK3 gene.[1][2][3]{{PBB_Summary | section_title = | summary_text = }}References1. ^{{cite journal | vauthors = Tassi E, Biesova Z, Di Fiore PP, Gutkind JS, Wong WT | title = Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor | journal = J Biol Chem | volume = 274 | issue = 47 | pages = 33287–95 |date=Dec 1999 | pmid = 10559204 | pmc = | doi =10.1074/jbc.274.47.33287 }} 2. ^{{cite journal | vauthors = Zhang W, Chen T, Wan T, He L, Li N, Yuan Z, Cao X | title = Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways | journal = Biochem Biophys Res Commun | volume = 274 | issue = 3 | pages = 872–9 |date=Sep 2000 | pmid = 10924369 | pmc = | doi = 10.1006/bbrc.2000.3244 }} 3. ^{{cite web | title = Entrez Gene: TAOK3 TAO kinase 3| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51347| accessdate = }}
Further reading{{refbegin | 2}}- {{cite journal |vauthors=Yoneda T, Imaizumi K, Oono K, etal |title=Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. |journal=J. Biol. Chem. |volume=276 |issue= 17 |pages= 13935–40 |year= 2001 |pmid= 11278723 |doi= 10.1074/jbc.M010677200 }}
- {{cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }}
- {{cite journal |vauthors=Yustein JT, Xia L, Kahlenburg JM, etal |title=Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38. |journal=Oncogene |volume=22 |issue= 40 |pages= 6129–41 |year= 2003 |pmid= 13679851 |doi= 10.1038/sj.onc.1206605 }}
- {{cite journal |vauthors=Ota T, Suzuki Y, Nishikawa T, etal |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }}
- {{cite journal |vauthors=Hartmann TB, Thiel D, Dummer R, etal |title=SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma. |journal=Br. J. Dermatol. |volume=150 |issue= 2 |pages= 252–8 |year= 2004 |pmid= 14996095 |doi=10.1111/j.1365-2133.2004.05651.x }}
- {{cite journal |vauthors=Gerhard DS, Wagner L, Feingold EA, etal |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 }}
- {{cite journal |vauthors=Rual JF, Venkatesan K, Hao T, etal |title=Towards a proteome-scale map of the human protein-protein interaction network. |journal=Nature |volume=437 |issue= 7062 |pages= 1173–8 |year= 2005 |pmid= 16189514 |doi= 10.1038/nature04209 }}
- {{cite journal |vauthors=Kimura K, Wakamatsu A, Suzuki Y, etal |title=Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. |journal=Genome Res. |volume=16 |issue= 1 |pages= 55–65 |year= 2006 |pmid= 16344560 |doi= 10.1101/gr.4039406 | pmc=1356129 }}
{{refend}}{{gene-12-stub}} |